Tag Archives: JUPITER

Doctor Urges Caution in Interpreting New Findings on Cholesterol Drug

On March 31, 2008, pharmaceutical giant AstraZeneca trumpeted the early closing of its so-called JUIPITER trial of a cholesterol-lowering drug (statin), Crestor. The results after only two years yielded “unequivocal evidence” of the drug’s effectiveness, the trial concluded, and the … Continue reading

Posted in Health Headlines, Heart Health, Medical Economics | Tagged , , , , , , | 2 Comments